RééDOC
75 Boulevard Lobau
54042 NANCY cedex

Christelle Grandidier Documentaliste
03 83 52 67 64


F Nous contacter

0

Article

--";3! O
     

-A +A

Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome

TOUBI E; KRAUSE I; FRASER A; LEV S; STOJANOVICH L; ROVENSKY J; BLANK M; SHOENFELD Y
CLIN EXP RHEUMATOL , 2005, vol. 23, n° 4, p. 499-504
Doc n°: 121746
Localisation : Documentation IRR
Descripteurs : FB3 - PATHOLOGIE VASCULAIRE

Objective Livedo reticularis (LR) is a skin vasculopathy that has been frequently described in patients with anti-phospholipid syndrome (APS) and reported to be present in association with valvular heart pathology and strokes (i.e. Sneddon's syndrome). Methods In a cohort of APS patients we investigated the possible association of LR with various clinical aspects of APS such as pregnancy morbidity, central nervous system (CNS) and cardiac manifestations. Results Livedo reticularis was found in 501308 (16%) of APS patients, and there was a significant association with cerebrovascular accidents (CVA), migraines and epilepsy (p = 0.01, 0.002, and 0.02 respectively). A similar association was also detected between LR, and the presence of cardiac valve thickening and vegetations (p = 0.001). No association with venous thrombosis, recurrent fetal loss, IUGR or toxemia was found. Conclusion Livedo reticularis is a frequent cutaneous manifestation in patients with APS. Its high association with cardiac and CNS thrombosis may suggest that LR-APS patients compose a subset at higher risk for thrombosis, and thus may require a closer follow-up and a more aggressive anticoagulation.

Langue : ANGLAIS

Tiré à part : OUI

Mes paniers

4

Gerer mes paniers

0